Concepedia

Beate Mayrbäurl

BM

Statistics

Publications

6

Citations

124

H-Index

6

Active since

2008

Affiliations

Klinikum Wels-Grieskirchen(Current)

Medical University of Graz

Innsbruck Medical University

Kepler Universitätsklinikum

Paracelsus Medical University

Beate Mayrbäurl is an author at Klinikum Wels-Grieskirchen specializing in chemotherapy, medicine, and oncology.

Publications per year

2008–2021

6

Publications

6

Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study

Beate Mayrbäurl, Johannes M. Giesinger, Sonja Burgstaller et al. · Supportive Care in Cancer · 2015 · 50 citations

Medicine, Oncology, Surgery +10

Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial

Felix Keil, Maximilian Hartl, Gabriela Altorjai et al. · European Journal of Cancer · 2021 · 20 citations

Medicine, Oncology, Chemotherapy +7

Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).

Ewald Wöll, Richard Greil, Wolfgang Eisterer et al. · PubMed · 2011 · 16 citations

Medicine, Oncology, Pharmacology +17

Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT)

Ewald Woell, R. Greil, Wolfgang Eisterer et al. · Journal of Clinical Oncology · 2009 · 15 citations

Medicine, Oncology, Pharmacology +15

Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric- 2

Ewald Woell, R. Greil, Wolfgang Eisterer et al. · Journal of Clinical Oncology · 2008 · 13 citations

Medicine, Oncology, Pharmacology +15

1–5 of 6